Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitors.
The presence of the common acute lymphoblastic leukemia antigen (CALLA) on leukemic cells from the great majority of patients with non-T cell acute lymphoblastic leukemia and chronic myelogenous leukemia in blast crisis suggests that CALLA could be differentiation antigen expressed by normal lymphoid and myeloid stem cells. Treatment with a murine monoclonal anti-CALLA antibody and complement lysed CALLA-positive leukemic cells quantitatively, whereas similar treatment of nucleated cells from peripheral blood and bone marrow failed to affect the expression, in semisolid culture, of CFU-G/E, BFU-E, CFU-E, or CFU-C. These data suggest that CALLA is not a normal differentiation antigen of the myeloid bipotent cell or its committed progenitors.
D000208:Acute Disease; D000951:Antigens, Neoplasm; D001777:Blood Coagulation; D001854:Bone Marrow Cells; D002454:Cell Differentiation; D002478:Cells, Cultured; D003114:Colony-Forming Units Assay; D003602:Cytotoxicity, Immunologic; D004912:Erythrocytes / Q000166:cytology*; D006098:Granulocytes / Q000166:cytology; D006410:Hematopoiesis; D006801:Humans; D007945:Leukemia, Lymphoid / Q000276:immunology*; D008747:Methylcellulose / Q000378:metabolism
D000951:Antigens, Neoplasm; D008747:Methylcellulose